This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Bostongene Corporation. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Ilia Galkin: Innovator in Tissue Imaging Techniques
Introduction
Ilia Galkin is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of tissue imaging, particularly through his innovative techniques in multiplexed immunofluorescence imaging. With a total of 2 patents to his name, Galkin is recognized for his advancements in determining tissue characteristics.
Latest Patents
Galkin's latest patents focus on techniques for determining tissue characteristics using multiplexed immunofluorescence imaging. These techniques involve obtaining at least one multiplexed immunofluorescence (MxIF) image of a tissue sample. The process includes gathering information indicative of cell locations within the MxIF image, identifying multiple groups of cells by determining feature values, and grouping these cells based on the identified features. Ultimately, these methods allow for the determination of at least one characteristic of the tissue sample using the multiple cell groups.
Career Highlights
Ilia Galkin is currently associated with Bostongene Corporation, where he continues to develop and refine his innovative techniques. His work has garnered attention in the scientific community, contributing to advancements in medical imaging and diagnostics.
Collaborations
Galkin collaborates with notable colleagues, including Viktor Svekolkin and Ekaterina Postovalova. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Ilia Galkin's contributions to tissue imaging through his patented techniques demonstrate his commitment to innovation in medical technology. His work continues to influence the landscape of tissue analysis and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
